Loxo Oncology, Inc. Contracts & Agreements
31 Contracts & Agreements
- Business Finance (12 contracts)
- Business Operations (4)
- Human Resources (7)
- Mergers & Acquisitions (1)
- Real Estate (3)
- Uncategorized (4)
- Agreement and Plan of Merger, dated January 5, 2019, by and among Eli Lilly and Company, Bowfin Acquisition Corporation and Loxo Oncology, Inc (Filed With SEC on January 7, 2019)
- Tender and Support Agreement, dated as of January 5, 2019, by and among Eli Lilly and Company, Bowfin Acquisition Corporation and Aisling Capital III, LP (Filed With SEC on January 7, 2019)
- 2014 Equity Incentive Plan, as amended April 23, 2018 and forms of award agreements (Filed With SEC on August 9, 2018)
- Non-Plan Stock Option Agreement (Inducement Stock Option Award) (Filed With SEC on August 9, 2018)
- Form of Amended and Restated Change of Control and Severance Agreement (Filed With SEC on May 8, 2018)
- Amended and Restated Employment Agreement (Filed With SEC on May 8, 2018)
- Agreement for the Assignment of Patents and other Rights and for the Novation of Certain Agreements, including for Product Manufacturing by and among the Registrant, Redx Pharma... (Filed With SEC on November 2, 2017)
- Assignment by and among the Registrant, Redx Pharma Plc and Redx Oncology Limited, and the individuals acting as Administrators, dated July 29, 2017 (Filed With SEC on November 2, 2017)
- Loxo Oncology, Inc. 3,150,000 Shares(1) Common Stock ($0.0001 par value) Underwriting Agreement (Filed With SEC on June 15, 2017)
- CHANGE IN CONTROL AND SEVERANCE AGREEMENT (Filed With SEC on March 7, 2017)
- Loxo Oncology, Inc. 3,870,000 Shares(1) Common Stock ($0.0001 par value) Underwriting Agreement (Filed With SEC on January 5, 2017)
- Loxo Oncology, Inc. 1,675,000 Shares(1) Common Stock ($0.0001 par value) Underwriting Agreement (Filed With SEC on May 12, 2016)
- AMENDMENT NO. 5 TO DRUG DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on March 15, 2016)
- Loxo Oncology, Inc. 2,500,000 Shares(1) Common Stock ($0.0001 par value) Underwriting Agreement (Filed With SEC on November 12, 2015)
- TWO STAMFORD PLAZA STAMFORD, CONNECTICUT OFFICE LEASE AGREEMENT BETWEEN ONE STAMFORD PLAZA OWNER LLC (LANDLORD) AND LOXO ONCOLOGY, INC. (TENANT) (Filed With SEC on November 10, 2015)
- Loxo Oncology, Inc. 1 Landmark Square, Suite 1122 Stamford, CT 06901 March 27, 2015 (Filed With SEC on May 14, 2015)
- AMENDMENT NO. 4 TO DRUG DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on May 14, 2015)
- AMENDMENT NO. 3 TO DRUG DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on March 27, 2015)
- LOXO ONCOLOGY, INC. 2013 EQUITY INCENTIVE PLAN As Adopted on July 2, 2013 As Amended on November 15, 2013 As Amended on April 23, 2014 As Amended on July 14, 2014 (Filed With SEC on July 30, 2014)
- [ ] Shares LOXO ONCOLOGY, INC. COMMON STOCK UNDERWRITING AGREEMENT (Filed With SEC on July 21, 2014)
- LOXO ONCOLOGY, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on July 21, 2014)
- INDEMNITY AGREEMENT (Filed With SEC on July 21, 2014)
- LOXO ONCOLOGY, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on July 21, 2014)
- LOXO ONCOLOGY, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on July 21, 2014)
- Loxo Oncology, Inc. 1 Landmark Square, Suite 1122 Stamford, CT 06901 July 1, 2014 (Filed With SEC on July 21, 2014)
- LOXO ONCOLOGY, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on June 30, 2014)
- LOXO ONCOLOGY, INC. 2013 EQUITY INCENTIVE PLAN As Adopted on July 2, 2013 As Amended on November 15, 2013 As Amended on April 23, 2014 (Filed With SEC on June 30, 2014)
- OFFICE LEASE of Suite 520 to LOXO ONCOLOGY, INC A Delaware corporation 400 Oyster Point Boulevard South San Francisco, CA 94080 (Filed With SEC on June 30, 2014)
- Sub-Lease Agreement (Filed With SEC on June 30, 2014)
- DRUG DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on June 30, 2014)
- LOXO ONCOLOGY, INC. FOUNDERS RESTRICTED STOCK PURCHASE AGREEMENT (Filed With SEC on June 30, 2014)
